SavedAdd your journal

Journals / The anatolian journal of family medicine (Online) / 2022 / Cilt: 5 - Sayı: 1

Tumor D’emblee Variant of Mycosis Fungoides

Manoj Kumar NAYAK
Aditi DHANTA
Naveen Kumar KANSAL
Ashok SİNGH
Prashant DURGAPAL
Pages
62–65
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this report, the rare presentation of sudden onset of tumor stage of MF (i.e., MF d’emblee variant) is presented.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Mycosis fungoides (MF) is a rare lymphoid malignancy and accounts for about 2% of new cases of non-Hodgkin’s lymphoma.
📊
Key Findings & Data:MF is known to have extensive clinical variability, usually progressing from patch stage to plaque, nodules, tumors, and generalized erythroderma.
💡
Conclusion & Impact:In this report, the rare presentation of sudden onset of tumor stage of MF (i.e., MF d’emblee variant) is presented.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Mycosis fungoides (MF) is a rare lymphoid malignancy and accounts for about 2% of new cases of non-Hodgkin’s lymphoma. MF is known to have extensive clinical variability, usually progressing from patch stage to plaque, nodules, tumors, and generalized erythroderma. In this report, the rare presentation of sudden onset of tumor stage of MF (i.e., MF d’emblee variant) is presented.

🔖

Cite This Article

NAYAK, M. K., DHANTA, A., KANSAL, N. K., SİNGH, A., DURGAPAL, P. (2022). Tumor D’emblee Variant of Mycosis Fungoides. The anatolian journal of family medicine (Online), Cilt: 5 - Sayı: 1, 62–65. https://ajindex.com/articles/407394

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Morgan EA, Murphy GF. Cutaneous lymphomas and leukemias. In: Elder DE, Elenitsas R, Rosenbach M, Murphy GF, Rubin AI, Xu X, editors. Lever’s histopathology of the skin. 11th ed. Philadelphia, PA: Wolters Kluwer; 2015
  2. Reddy K, Bhawan J. Histologic mimickers of mycosis fungoides: a review. J Cutan Pathol 2007;34:519–25
  3. Hoppe RT, Advani R, Kim YH. Mycosis fungoides. In: Hoppe RT, Phillips TL, Roach M, eds. Leibel and Phillips’ textbook of radiation oncology. 3rd ed. Philadelphia, PA: Elsevier Saunders; 2010. p. 1380–93
  4. Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers. J Am Acad Dermatol 2014;70(2):205.e1–16; quiz 221–2
  5. Vidal E, Brocq L. Etude sur le mycosis fungoide. Fr Med 1885;2:946–1085
  6. O’quinn RP, Zic JA, Boyd AS. Mycosis fungoides d’embleé: CD30-negative cutaneous large T-cell lymphoma. J Am Acad Dermatol 2000;43:861–3
  7. Bagot M, Stadler R. Cutaneous lymphoma. In: Kang S, Amagai M, Bruckner AL, Enk AH, Margolis DJ, McMichael AJ, Orringer JS, editors. Fitzpatrick’s dermatology. 9th ed. New York: Mc- Graw-Hill; 2019. p. 2072–107
  8. Chokoeva AA, Tchernev G. Mycosis fungoides: The multicentric tumor d’emblee. Mayo Clin Proc 2015;90:1746–47
  9. Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions. J Am Acad Dermatol 2014;70:223.e1–17.